Toggle light / dark theme

Dr. Joni L. Rutter, Ph.D., (https://ncats.nih.gov/director/bio) is the Director of the National Center for Advancing Translational Sciences (NCATS — https://ncats.nih.gov/) at the U.S. National Institutes of Health (NIH) where she oversees the planning and execution of the Center’s complex, multifaceted programs that aim to overcome scientific and operational barriers impeding the development and delivery of new treatments and other health solutions. Under her direction, NCATS supports innovative tools and strategies to make each step in the translational process more effective and efficient, thus speeding research across a range of diseases, with a particular focus on rare diseases.

By advancing the science of translation, NCATS helps turn promising research discoveries into real-world applications that improve people’s health. The NCATS Strategic Plan can be found at — https://ncats.nih.gov/strategicplan.

In her previous role as the NCATS deputy director, Dr. Rutter collaborated with colleagues from government, academia, industry and nonprofit patient organizations to establish robust interactions with NCATS programs.

Prior to joining NCATS, Dr. Rutter served as the director of scientific programs within the All of Us Research Program, where she led the scientific programmatic development and implementation efforts to build a national research cohort of at least 1 million U.S. participants to advance precision medicine. During her time at NIH, she also has led the Division of Neuroscience and Behavior at the National Institute on Drug Abuse (NIDA). In this role, she developed and coordinated research on basic and clinical neuroscience, brain and behavioral development, genetics, epigenetics, computational neuroscience, bioinformatics, and drug discovery. Dr. Rutter also coordinated the NIDA Genetics Consortium and biospecimen repository.

Throughout her career, Dr. Rutter has earned an international reputation for her diverse and unique expertise via her journal publications and speaking engagements, and she has received several scientific achievement awards, including the 2022 Rare Disease Legislative Advocates–RareVoice Award for Federal Advocacy and the 2022 FedHealthIT–Women in Leadership Impact Award.

Dr. Rutter received her Ph.D. from the Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire, and completed a fellowship at NCI within the Division of Cancer Epidemiology and Genetics.

The thyroid is a butterfly-shaped gland in your lower neck. It produces hormones that help regulate your metabolism, temperature and energy levels.

Thyroid cancer develops when cells within the thyroid mutate and grow abnormally. Thyroid cancer symptoms can be subtle early on and sometimes are blamed on an infection or a seasonal allergy. Thyroid cancer is highly treatable using a variety of methods.

It’s notoriously difficult for doctors to identify a wound that is becoming infected. Clinical signs and symptoms are imprecise and methods of identifying bacteria can be time-consuming and inaccessible, so a diagnosis can be subjective and dependent on clinician experience. But infection can stall healing or spread into the body if it isn’t treated quickly, putting a patient’s health in grave danger. An international team of scientists and clinicians thinks they have the solution: a device run from a smartphone or tablet app, which allows advanced imaging of a wound to identify infection.

“Wound care is one of today’s most expensive and overlooked threats to patients and our overall health care system,” said Robert Fraser of Western University and Swift Medical Inc., corresponding author of the study published in Frontiers in Medicine. “Clinicians need better tools and data to best serve their patients who are unnecessarily suffering.”

The scientists developed a device called the Swift Ray 1, which can be attached to a smartphone and connected to the Swift Skin and Wound software. This can take medical-grade photographs, infrared thermography images (which measure body heat), and bacterial fluorescence images (which reveal bacteria using violet light).

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.

At-Home Blood Testing (SiPhox Health): https://getquantify.io/mlustgarten.

Talk with Your Allergy Care Team About Your Concerns.

If managing the social and emotional impacts of your atopic condition feels stressful and overwhelming, know that you’re not alone. More importantly, know that you don’t have to navigate those feelings alone either!

Your allergy healthcare team is a great place to start if you feel like you need additional support in managing your allergic condition. By discussing your concerns or struggles with them, they can offer useful evidence-based information, skills, and resources, as well as allied health care referrals.

Now maybe we can snack happily! I think this applies to regular food too? I can eat all the Chinese and Mexican and Italian food I want? Plus for people with genetic risks can’t this not help? I hope so.


Mice fed a high-sugar, high-fat diet for most of their lives managed to escape weight gain and protect their livers when they were treated with an experimental new drug.

The small-molecule drug was developed by a team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio). K nown by its chemical acronym CPACC, it works by limiting the entry of magnesium into the mitochondria, the parts of the cell in charge of generating energy and burning calories.

Mitochondrial abnormalities have been implicated in a range of diseases, including obesity, diabetes, and cardiovascular disease.

Bond, a new startup in New York City, has created robots that can learn your handwriting and convert digital notes into personalized letters.
» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews.

NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and our original series Debunker, Flashback, Nerdwatch, and Show Me. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations.

Connect with NBC News Online!
Visit NBCNews. Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Follow NBC News on Google+: http://nbcnews.to/PlusNBC
Follow NBC News on Instagram: http://nbcnews.to/InstaNBC
Follow NBC News on Pinterest: http://nbcnews.to/PinNBC

Note-writing robots pen letters in your handwriting | NBC news.

Artificial Intelligence makes art, knows more than many humans and works faster than they do. But will people accept AI-controlled social robots working in the service industry or entertaining those in need of care?

What does a robot need to have to be accepted as a social partner by a human being? Does it need a face? Should the machine understand — or even show — emotions?

The psychologist, neurologist and philosopher Agnieszka Wykowska, currently researching at the Italian Institute of Technology in Genoa, says: “We tend to humanize everything. We even see faces in car hoods. This is further reinforced whenever a robot demonstrates humanlike behavior.

In a care home for the elderly in Rendsburg, the film shows what sort of relationship forms between residents and robots. Hannes Eilers from the Kiel University of Applied Sciences is carrying out tests there with robots for health insurance companies. The robots sing with the elderly people, play games or demonstrate physio exercises. The one thing they’re not allowed to do with them is pray. The systems there function autonomously. This means they can’t access an AI server, so they abide by data protection laws.

But AI servers are already controlling much of our communication. They don’t just suggest what we should read, eat or buy next: ‘chatbots’ also serve as personal contacts. At the Massachusetts Institute of Technology (MIT) in Boston, the scientist Hossein Rahnama is working on perfecting the appearance and communication skills of chatbots like these. His view: “We now have access to such immense computing power and data that we can create a digital version of every person. Before too long, we can even make them sentient.

In future, will we be able to tell the difference between a flesh-and-blood human, and their digital clone?

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.

At-Home Blood Testing (SiPhox Health): https://getquantify.io/mlustgarten.